Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular folks, right? Well, InMode (NASDAQ: INMD) has a patented platform that changes the game.
InMode is the developer, manufacturer, and seller of minimally invasive platforms used primarily for cosmetic procedures and health . The stock at one point had risen over 1,000% after its initial public offering that occurred in 2019 and was up more than 180% by Q4 2021. However, the stock has fallen significantly since Nov. 1, which offers investors a compelling entry point.
For further details see:
InMode Is Bringing a Paradigm Shift to Cosmetic Procedures